Daniel Wolff - Concepedia

Author

Daniel Wolff

Also Known As

D Wolff, D. WOLFF, D. Wolff, Daniel A. Wolff, Daniel Wolff, Johan Maertens, Matthias Edinger, Saroj Ghimire, Wolff D., Wolff, D.A.

437

Publications

15.1K

Citations

H-Index

175

Concepts

All Affiliations

University Hospital Regensburg University of Regensburg Medical University of Vienna University of Rostock Fred Hutch Cancer Center

About

Daniel Wolff is an author at University Hospital Regensburg specializing in medicine, transplantation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	59	9.1K
2	Health Sciences	13	14	1.3K
3	Engineering	2	2	78
4	Public Health	2	2	82
5	Education	1	1	27

Daniel Wolff

126

Publications

13.5K

Citations

H-Index

Page 1

	Year	Citations
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report Madan Jagasia, Hildegard Greinix, Mukta Arora, Biology of Blood and Marrow Transplantation Solid Organ TransplantationImmunologyPathologySurgeryChronic Gvhd	2014	5.2K
Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease Ernst Holler, Peter Butzhammer, Karin Schmid‐Zalaudek, Biology of Blood and Marrow Transplantation DysbiosisAllogeneic SctMicrobial PathogensGastroenterologySystemic Antibiotics	2014	516
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment Hélène Schoemans, Stephanie J. Lee, James L.M. Ferrara, Bone Marrow Transplantation	2018	460
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich, Journal of Allergy and Clinical Immunology Clinical ImmunologyAllergyLymphocyte DevelopmentMedicineImmunodeficiencies	2018	423
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report Stephanie J. Lee, Daniel Wolff, Carrie L. Kitko, Biology of Blood and Marrow Transplantation	2015	402
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease Daniel Wolff, Michael Schleuning, Stephanie von Harsdorf, Biology of Blood and Marrow Transplantation Cell TherapyImmunologyBiological TherapyPharmacotherapyImmunotherapy	2010	329
Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation Vanya Icheva, Simone Kayser, Daniel Wolff, Journal of Clinical Oncology	2012	266
Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD Daniel Wolff, Armin Gerbitz, Francis Ayuk, Biology of Blood and Marrow Transplantation	2010	245
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation Daniela Weber, Robert R. Jenq, Jonathan U. Peled, Biology of Blood and Marrow Transplantation	2017	234
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, Nature Medicine DysbiosisCancer ImmunosurveillanceMucosal ImmunologyClinical ResponsesImmunology	2023	206

Page 1